首页 | 本学科首页   官方微博 | 高级检索  
     


Antiphospholipid syndrome development after rituximab treatment
Authors:Faillace César  de Carvalho Jozélio Freire
Affiliation:1. Hospital For Special Surgery, Weill Cornell Medical College, New York, NY, USA;2. Department of Rheumatology, University of São Paulo School of Medicine, São Paulo, Brazil;3. Department of Hematology, University College London Hospitals NHS Foundation Trust and University College London, London UK;4. Lupus Unit, Guys'' and St Thomas Foundation Trust, London, UK;5. Department of Rheumatology, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil;6. Department of Rheumatology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil;7. Hemostasis and Thrombosis Center, Duke University Medical Center, Durham, NC, USA;8. First Department of Medicine, University of Athens School of Medicine, Athens, Greece;9. Division of Rheumatology,University of Texas Medical Branch, Galveston, TX, USA;1. Department of Autoimmune Diseases, Institut d''Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Catalonia, Spain;2. Université Paris 5, Paris, France;3. The Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY, USA;4. The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel;5. AP-HP, Service de Médecine Interne, Centre des Maladies Rares, Hôpital Cochin, Paris, France
Abstract:
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号